Plus Therapeutics tumbles on $15M private placement
Plus therapies decrease $ 15 million on private placement
Report
Similar Posts
32.1% of Warren Buffett’s $295 Billion Portfolio Is Invested in 4 Artificial Intelligence (AI) Stocks
Did you invest $1,000? Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) When Warren Buffett became its CEO in…
Bleak times for copper smelters as conversion fees slump: Andy Home By Reuters
By Andy Homme LONDON (Reuters) – An unprecedented collapse in conversion fees is creating tough times…
US agrees maritime ceasefire deal with Ukraine and Russia
Stay informed with free updates Just sign up to War in Ukraine MYFT DIGEST – Shipped…
Sarepta exceeds revenue forecasts, maintains 2025 guidance By Investing.com
CAMBRIDGE, Mass. Sarepta Therapeutics, Inc. (NASDAQ: ) the $11.95 billion market cap biotechnology company specializing in…
English